Herbalife Nutrition (HLF) Tops Q2 EPS by 9c

Herbalife Nutrition (NYSE: HLF) reported Q2 EPS of $0.95, $0.09 better than the analyst estimate of $0.86. Revenue for the quarter came in at $1.3 billion versus the consensus estimate of $1.3 billion.

Outlook

The extent and duration of business disruption and related financial impact from the COVID-19 pandemic cannot be reasonably estimated at this time but could materially impact our business, financial condition and consolidated results for the third quarter and full year 2020. The Company will periodically reassess its ability to provide guidance as and when we believe the impact of the pandemic can be reasonably estimated.

For earnings history and earnings-related data on Herbalife Nutrition (HLF) click here.

You May Also Be Interested In

• Gilead Sciences (GILD) Misses Q1 EPS by 288c
• PTC Therapeutics (PTCT) Tops Q1 EPS by 9c, provides guidance
• ResMed (RMD) Tops Q3 EPS by 20c